Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer’s Disease

Abstract Glucose is the central nervous system’s only energy source. Imaging techniques capable to detect pathological alterations of the brain metabolism are useful in different diagnostic processes. Such techniques are also beneficial for assessing the evaluation efficacy of therapies in pre-clini...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Daniele Tolomeo, Edoardo Micotti, Sonia Colombo Serra, Michael Chappell, Anniina Snellman, Gianluigi Forloni
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/2963ada7571f471d909d643ef6001e76
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:2963ada7571f471d909d643ef6001e76
record_format dspace
spelling oai:doaj.org-article:2963ada7571f471d909d643ef6001e762021-12-02T15:07:59ZChemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer’s Disease10.1038/s41598-018-27839-72045-2322https://doaj.org/article/2963ada7571f471d909d643ef6001e762018-06-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-27839-7https://doaj.org/toc/2045-2322Abstract Glucose is the central nervous system’s only energy source. Imaging techniques capable to detect pathological alterations of the brain metabolism are useful in different diagnostic processes. Such techniques are also beneficial for assessing the evaluation efficacy of therapies in pre-clinical and clinical stages of diseases. Chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) is a possible alternative to positron emission tomography (PET) imaging that has been widely explored in cancer research in humans and animal models. We propose that pathological alterations in brain 2-deoxy-D-glucose (2DG) uptake, typical of neurodegenerative diseases, can be detected with CEST MRI. Transgenic mice overexpressing a mutated form of amyloid precusrsor protein (APP23), a model of Alzheimer’s disease, analyzed with CEST MRI showed a clear reduction of 2DG uptake in different brain regions. This was reminiscent of the cerebral condition observed in Alzheimer’s patients. The results indicate the feasibility of CEST for analyzing the brain metabolic state, with better image resolution than PET in experimental models.Daniele TolomeoEdoardo MicottiSonia Colombo SerraMichael ChappellAnniina SnellmanGianluigi ForloniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-10 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Daniele Tolomeo
Edoardo Micotti
Sonia Colombo Serra
Michael Chappell
Anniina Snellman
Gianluigi Forloni
Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer’s Disease
description Abstract Glucose is the central nervous system’s only energy source. Imaging techniques capable to detect pathological alterations of the brain metabolism are useful in different diagnostic processes. Such techniques are also beneficial for assessing the evaluation efficacy of therapies in pre-clinical and clinical stages of diseases. Chemical exchange saturation transfer (CEST) magnetic resonance imaging (MRI) is a possible alternative to positron emission tomography (PET) imaging that has been widely explored in cancer research in humans and animal models. We propose that pathological alterations in brain 2-deoxy-D-glucose (2DG) uptake, typical of neurodegenerative diseases, can be detected with CEST MRI. Transgenic mice overexpressing a mutated form of amyloid precusrsor protein (APP23), a model of Alzheimer’s disease, analyzed with CEST MRI showed a clear reduction of 2DG uptake in different brain regions. This was reminiscent of the cerebral condition observed in Alzheimer’s patients. The results indicate the feasibility of CEST for analyzing the brain metabolic state, with better image resolution than PET in experimental models.
format article
author Daniele Tolomeo
Edoardo Micotti
Sonia Colombo Serra
Michael Chappell
Anniina Snellman
Gianluigi Forloni
author_facet Daniele Tolomeo
Edoardo Micotti
Sonia Colombo Serra
Michael Chappell
Anniina Snellman
Gianluigi Forloni
author_sort Daniele Tolomeo
title Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer’s Disease
title_short Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer’s Disease
title_full Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer’s Disease
title_fullStr Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer’s Disease
title_full_unstemmed Chemical exchange saturation transfer MRI shows low cerebral 2-deoxy-D-glucose uptake in a model of Alzheimer’s Disease
title_sort chemical exchange saturation transfer mri shows low cerebral 2-deoxy-d-glucose uptake in a model of alzheimer’s disease
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/2963ada7571f471d909d643ef6001e76
work_keys_str_mv AT danieletolomeo chemicalexchangesaturationtransfermrishowslowcerebral2deoxydglucoseuptakeinamodelofalzheimersdisease
AT edoardomicotti chemicalexchangesaturationtransfermrishowslowcerebral2deoxydglucoseuptakeinamodelofalzheimersdisease
AT soniacolomboserra chemicalexchangesaturationtransfermrishowslowcerebral2deoxydglucoseuptakeinamodelofalzheimersdisease
AT michaelchappell chemicalexchangesaturationtransfermrishowslowcerebral2deoxydglucoseuptakeinamodelofalzheimersdisease
AT anniinasnellman chemicalexchangesaturationtransfermrishowslowcerebral2deoxydglucoseuptakeinamodelofalzheimersdisease
AT gianluigiforloni chemicalexchangesaturationtransfermrishowslowcerebral2deoxydglucoseuptakeinamodelofalzheimersdisease
_version_ 1718388304870637568